Pharmaceutical preparations for treatment of cancer and viral diseases; proteins for treatment of cancer and viral diseases; protein fragments for treatment of cancer and viral diseases; protein conjugates for treatment of cancer and viral diseases; pharmaceutical preparations, namely, anti-cancer and anti-viral agents; pharmaceutical preparations, proteins, protein fragments and protein conjugates all for treatment of immunologic diseases, particularly autoimmune diseases

proteins for use in the manufacture of pharmaceutical preparations for treating cancer and viral diseases; protein fragments for use in the manufacture of pharmaceutical preparations for treating cancer and viral diseases; protein conjugates for use in the manufacture of pharmaceutical preparations for treating cancer and viral diseases; and anti-cancer and anti-viral agents for use in the manufacture of pharmaceutical preparations for treating cancer and viral diseases